%PDF-1.4
%
46 0 obj
<>
endobj
43 0 obj
<>
endobj
114 0 obj
<>stream
Acrobat Distiller 4.05 for Macintosh
2004-11-12T10:44:06Z
2024-03-28T04:14:19-07:00
QuarkXPressª 4.11: AdobePS 8.8.0 (301)
2024-03-28T04:14:19-07:00
application/pdf
Heather
2004-24.dec
uuid:f04b16a1-1dd1-11b2-0a00-f409276d7200
uuid:f04b16a4-1dd1-11b2-0a00-b80000000000
endstream
endobj
32 0 obj
<>
endobj
33 0 obj
<>
endobj
47 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 16 0 R/Type/Page>>
endobj
1 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 18 0 R/Type/Page>>
endobj
4 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 20 0 R/Type/Page>>
endobj
7 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 22 0 R/Type/Page>>
endobj
10 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 24 0 R/Type/Page>>
endobj
13 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 26 0 R/Type/Page>>
endobj
136 0 obj
[140 0 R]
endobj
137 0 obj
<>stream
q
0 0 612 792 re
W n
BT
0.85091 0.85091 0.85091 rg
/T1_0 19 Tf
0.6229 0.7822 -0.7822 0.6229 12.739 54.1879 Tm
(Personal non-commercial use only. The Journal of Rheumatology. Copyright\
\251 2004. All rights reserved)Tj
ET
Q
1 g
/GS0 gs
0 792 m
0 792 l
f
q
12 789 587 -785 re
W n
q
0 792.03 612 -792 re
W n
BT
0 0 0 1 k
/GS1 gs
/T1_1 1 Tf
-0.00011 Tc 0.02499 Tw 8 0 0 8 73.9 736.6941 Tm
(of the knee. Rheumatology Oxford 1999;38:870-7.)Tj
-2.175 -1.25 Td
[(13.)-875.1 (Soderman P)110.8 (, Malchau H. )17.7 (V)110.8 (alidity and reliability of Swedish)]TJ
2.175 -1.25 Td
(WOMAC osteoarthritis index: a self-administered disease-specific)Tj
0 -1.25 TD
(questionnaire \(WOMAC\) versus generic instruments \(SF-36 and)Tj
T*
[(NHP\). )54.8 (Acta Orthop Scand 2000;71:39-46.)]TJ
-2.175 -1.25 Td
[(14.)-875.1 (Jones CA, )17.7 (V)128.9 (oaklander DC, Johnston DW)91.7 (, Suarez-Almazor ME.)]TJ
2.175 -1.25 Td
(Health related quality of life outcomes after total hip and knee)Tj
T*
(arthroplasties in a community based population. J Rheumatol)Tj
0 Tc 0 Tw T*
(2000;27:1745-52.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(15.)-875.1 (W)79.9 (oo J, Ho SC, Lau J, Leung PC. Musculoskeletal complaints and)]TJ
2.175 -1.25 Td
[(associated consequences in elderly Chinese aged 70 years and over)54.8 (.)]TJ
T*
(J Rheumatol 1994;21:1927-31.)Tj
-2.175 -1.25 Td
[(16.)-875.1 (Lau EMC, Symmons DPM, Croft P)110.7 (.)-0.1 ( )17.7 (The epidemiology of hip)]TJ
2.175 -1.25 Td
(osteoarthritis and rheumatoid arthritis in the Orient. Clin Orthop)Tj
0 Tc 0 Tw T*
(1996;323:81-90.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(17.)-875.1 (Hochber)17.7 (g MC, Chang R)54.8 (W)91.9 (, Dwosh I, Lindsey S, Pincus )17.7 (T)74 (,)-0.1 ( )17.7 (W)79.9 (olfe F)79.7 (.)]TJ
2.175 -1.25 Td
[(The )54.8 (American College of Rheumatology 1991 revised criteria for)]TJ
T*
(the classification of global functional status in rheumatoid arthritis.)Tj
T*
(Arthritis Rheum 1992;35:498-502.)Tj
-2.175 -1.25 Td
[(18.)-875.1 (Lam CLK, Lauder IJ, Lam )17.7 (TP)110.8 (, Gandek B. Population based )]TJ
2.175 -1.25 Td
[(norming of the Chinese \(HK\) version of the SF-36 health survey)64.8 (.)]TJ
T*
(Hong Kong Pract 1999;21:460-70.)Tj
-2.175 -1.25 Td
[(19.)-875.1 (McConnell S, Kolopack P)110.7 (, Davis )54.8 (AM. )17.7 (The )17.7 (W)79.9 (estern Ontario and)]TJ
2.175 -1.25 Td
(McMaster Universities Osteoarthritis Index \(WOMAC\): a review)Tj
T*
[(of its utility and measurement properties. )54.8 (Arthritis Rheum)]TJ
0 Tc 0 Tw T*
(2001;45:453-61. )Tj
0.02499 Tw -2.175 -1.25 Td
[(20.)-875 (Y)110.9 (uan HJ, Zhang J, Sun M, Kwok CY)128.9 (, )36.9 (Y)99.9 (eung F)79.8 (, )17.8 (W)80 (oo J. )54.9 (A)]TJ
-0.00011 Tc 2.175 -1.25 Td
(comparison of the quality of life between stroke survivors at 6-9)Tj
T*
(months and those at two years [Chinese]. Geriatr Health Care)Tj
0 Tc 0 Tw T*
(2002;8:17-20. )Tj
-0.00011 Tc 0.02499 Tw 30.825 36.25 Td
[(21.)-875.1 (Lam CL, Lauder IJ. )17.7 (The impact of chronic diseases on the )]TJ
2.175 -1.25 Td
(health-related quality of life of Chinese patients in primary care.)Tj
T*
(Fam Pract 2000;17:159-66.)Tj
-2.175 -1.25 Td
[(22.)-875.1 (Lavernia CJ, Guzman JF)79.7 (, Gachupin-Garcia )54.8 (A. Cost ef)17.7 (fectiveness)]TJ
2.175 -1.25 Td
[(and quality of life in knee arthroplasty)64.8 (. Clin Orthop )]TJ
0 Tc 0 Tw T*
(1997;345:134-9.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(23.)-875.1 (T)69.9 (owheed )17.7 (TE, Hochber)17.7 (g MC. Health-related quality of life after)]TJ
2.175 -1.25 Td
[(total hip replacement. Semin )54.8 (Arthritis Rheum 1996;26:483-91.)]TJ
-2.175 -1.25 Td
[(24.)-875.1 (Jonas CA, )17.7 (V)128.9 (oaklander DC, Johnston DW)91.7 (, Suarez-Almazor ME. )17.7 (The)]TJ
2.175 -1.25 Td
[(ef)17.7 (fect of age on pain, function, and quality of life after total hip and)]TJ
T*
[(knee arthroplasty)64.8 (. )54.8 (Arch Intern Med 2001;161:454-60.)]TJ
-2.175 -1.25 Td
[(25.)-875.1 (V)110.8 (allerand )54.8 (AH. Gender dif)17.7 (ferences in pain. Image J Nurs Sch)]TJ
0 Tc 0 Tw 2.175 -1.25 Td
(1995;27:235-7.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(26.)-875.1 (Marmot M, )17.7 (W)39.8 (ilkinson RG, editors. Social determinants of health.)]TJ
2.175 -1.25 Td
[(New )36.8 (Y)99.8 (ork: Oxford University Press; 1999.)]TJ
-2.175 -1.25 Td
[(27.)-875.1 (Zhang )36.8 (Y)128.9 (, Xu L, Nevitt MC, et al. Comparison of the prevalence of)]TJ
2.175 -1.25 Td
(knee osteoarthritis between the elderly Chinese population in)Tj
T*
[(Beijing and whites in the United States: )17.7 (The Beijing Osteoarthritis)]TJ
T*
[(Study)64.8 (. )54.8 (Arthritis Rheum 2001;44:2065-71.)]TJ
-2.175 -1.25 Td
[(28.)-875.1 (W)79.9 (oo J, Lau E, Lau CS, et al. Socioeconomic impact of )]TJ
2.175 -1.25 Td
(osteoarthritis in Hong Kong Chinese: utilization of health and)Tj
T*
[(social services, direct and indirect costs. )54.8 (Arthritis Care Res)]TJ
0 Tc 0 Tw T*
(2003;49:526-34.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(29.)-875.1 (Karlson EW)91.7 (, Daltroy LH, Liang MH, Eaton HE, Katz JN. Gender)]TJ
2.175 -1.25 Td
[(dif)17.7 (ferences in patient preferences may underlie dif)17.7 (ferential )]TJ
T*
[(utilization of elective sur)17.7 (gery)64.9 (. )54.8 (Am J Med 1997;102:524-30.)]TJ
ET
0 0 0 1 K
53.46 77 m
558.47 77 l
S
0 0 0 0 k
52.32 70.06 64.18 -15.66 re
f*
BT
0 0 0 1 k
/T1_2 1 Tf
0 Tc 0 Tw 8 0 0 8 53.3216 57.1344 Tm
(2438)Tj
ET
0 0 0 0 k
355.5 70.06 203 -15.66 re
f*
BT
0 0 0 1 k
/T1_2 1 Tf
-0.00011 Tc 0.02499 Tw 8 0 0 8 419.8613 57.1344 Tm
(The Journal of Rheumatology 2004; 31:12)Tj
ET
0 0 0 0 k
/GS0 gs
101.13 81.08 407.5 -10.83 re
f*
0.5 w
101.13 81.08 407.5 -10.83 re
S
Q
Q
q
0 0 612 792 re
W n
BT
0 0 0 rg
/GS2 gs
/T1_3 8 Tf
112.368 73 Td
(Personal, non-commercial use only. The Journal of Rheumatology. Copyri\
ght \251 2004. All rights reserved.)Tj
ET
Q
BT
0 g
/GS2 gs
/T1_4 1 Tf
10 0 0 10 540 17 Tm
( )Tj
0 0.48627 0.77255 rg
/GS2 gs
-7.22298 0 Td
(www.jrheum.org)Tj
0 g
/GS2 gs
-16.72996 0 Td
(Downloaded on March 28, 2024 from )Tj
ET
endstream
endobj
26 0 obj
<>stream
8;Z\7!KP#N%*SZ8R-u$AfQDOT)++K4`=jrXQ8jno$MVDU_9?f#gZSM@bZEPaq!.5l
$hUsW:5mT]hNifGg(-h[bT/MaOD1eamg!6.f=tP:%"U_lL_XJHOfV3?f0Qt&f/GFX
&+Nhe3mH\_6#3?0.81LkUbVM_L$2hu'K=VL`PjjJZ?n`XJkcj(m7c:'*f,+:*@h7,
s5t/XHs#cj'dO:#)GdZ\C@/DqP<>"A_gbi.e0
MXQ+&OTO(lY18XK4>Se[QBDD.=Oj6=lEQj?[(FOs=f!aad:n+H,M#Alo6,pfhS'i`?maufbLhJCM=Oa;Kii]':lViZObb3NHmj@$HD'>'M
]mNq0:kJj;>+7SGL`A/j[]H^U`']1HhhLt
endstream
endobj
30 0 obj
[/Indexed/DeviceRGB 255 29 0 R]
endobj
29 0 obj
<>stream
J,g]g+e/h_!_gCtO=0f)$P%cIi8Zdfc5&3j_8$7g.@L`YKUJNGBP\poR=_;Dl'P(T
(7Boo^^S:71(MN]ZQX/+Cbu.lK"p74pe1T%s.DY%&\1TdJhr54.M9au6>79n6`Q:4
PbLSZTLEE(8E@'*1mg_*eTnN*;*'V3+gm-EEetX%;Bo$ur2ss*N`.-!.kG_q6GDD'
dKoL!8Ka#EV,@V!\j8ZFbp6EE<9cn=N6j0nf;(&;QU6bUD')c@\
9-d\DA=cZ0Q>gIM$$;cd2O@&a;X,Nn_aP(]I1aRc(K1^ue>
gF/(+GaKo$qneLWDrQ#;5\S(\$q'4Q,85`-8;S(=Z"WSBOV*FM)4,?B],R
endstream
endobj
101 0 obj
<>
endobj
53 0 obj
<>
endobj
51 0 obj
<>
endobj
88 0 obj
<>
endobj
119 0 obj
<>
endobj
54 0 obj
<>
endobj
81 0 obj
<>stream
HUkPgGO(O ZJQkAQ!rS @.@BBB& JR.rVzElk:]fn<9yEOOJ)@*d;R*IR$!J|feL~#D,:Q/<8}rx;S9ճS><9+xb6k/}c};qSC_V8Չ]qId
͂wDO^9sơou+%4nɊ){mZ8BuP{sGL5:Cʠ(E[vɻ;;oں^{E.%갯ǫpԙ \_=#)՛WǂxGMk|d-56"_i9g+5MiyE.ٮ<.3IsDy<@V.G
Q$
Y,U0ݟ`'vy[&r8Sp;8ȸUZ4+ͫXhgb[jurk]g4,F+v}5Kn3̊;#QGɅK5Oa9):9X &\B7\Ů8,f!T[CԤ߭J;+;9XyH7?oLz.%mbgA0|_lQÖۙ7/^'Dn
CevNͺ¦o6v"+:<(c&DЯޢƒeٔ&":]Y"B+-5kgy
U2sB;FYOVPuZۻ>kztyDV5d6CZ]?7ӫ\c|r7W*bfEad_, EMFH稇+`N>L!i¶mܠ4IaFeLy=N,B(P*ќM^BSNs3fԐU+;.QCq
XAA] )ʳ|`j"E:4E0>J6ϋFI⣇jsZajzcX\b%g5cgq5O¿g>Nny)9jo
Ts
si"yB{Y;]\!7v<۷NH9Kxi;xrCM
- A\@kHCcy{hI՟nۓJϕ۹3v'jp<:dIp`MN0qo%8PX'\fF3])toӿGmGrZ+`Αz|5 %O#+bXXv
&x:
v>^Cr|"R"igfoe鈷]U F''ZSCyW\`8Fn+An_(nk*j%q85P3mbQVQQQ
fc քNja7(("Ti+n3ucujx-3;-[SI饊ʭ&Fs*dN̞X'I\qkZbF!G49#[/(]T?P2M1GU$JKvq+wwH/`yi<0+QK}_͠=&X
lm
z48/Kn?أ9Y*8/P;l
_^CTN glX "l@4ٗKۏ!HbYH}֗쟳Hvl9e9VJO,<%(*QAa[P0$t4IXA0'!<6g©IV@b!\A̚+ Ɏ,a*<ӏC1
5$S<Lhom(
dWtSH}Ԁc+&FneA6%!GsQJtqqmH:P# pxcW5a:] 稻``Xє RIUu}f%$D)}alQH#ut1|Hxd/P)mRRMr8AH=ⲎKZ`b>\1azP+YzgDYACߒOz+o}T
6=I@)[B`4
!܃XLSn;YCK0%&@KŬKʝR+M9I H3l1nh}Nm }3
}n+b=;|f`3}!09o_S7k 'Trxij6VoXgk:%\#xjIaË/G+y0u(rGpXM[#cޜ?CPh?W-ӏ&hXF:`yphm2@執F_E.h>7EN(aV${<}F8xd_e<ۨ<z)lqEE^ȹBU-Y#L:(t=g6!
ɒpr8&h%&-=d/@%